Becton Dickinson CEO Sells Shares Following Earnings Beat and Dividend Increase

Becton Dickinson and Company reported that its Chairman, Chief Executive Officer, and President, Thomas E. Polen Jr., sold 2,993 shares of company stock for $629K at a price of $210.00 each on Nov 5, 2026. According to a regulatory filing, Polen acquired 20,239 shares through derivative exercises at $178.94 and returned 17,246 shares to the company at $210.00. Following the transactions, he directly owned 110,163 shares.

The insider transaction coincided with an announcement regarding shareholder payouts. On Nov. 5, the medical technology firm declared a regular dividend of $1.06 per share, payable on Dec. 31. The company's dividend yield stood at 2.01%, with its payout ratio at 32% of earnings after increasing its payout eight times across the prior five years.

The company also released its results for the quarter ended September 2026, surpassing Wall Street expectations. Becton Dickinson recorded adjusted earnings of $4.15 per share, exceeding the Zacks Consensus Estimate of $4.06 per share and advancing from $3.96 per share in the year-ago period. Quarterly revenue arrived at $5.27 billion, beating projections by 2.96%, though down from $5.89 billion recorded in the same period of the previous year.

Looking forward, consensus estimates compiled by Zacks project coming quarter earnings of $2.69 per share on $4.77 billion in revenue, alongside full-year figures of $13.24 per share on $19.91 billion in revenue. Analysts at Zacks Investment Research assigned the shares a Zacks Rank #2 (Buy), anticipating the stock to outperform the broader market in the near term.

As of Nov 11, Becton Dickinson shares stood at $214.52 on the New York Stock Exchange, putting its market capitalization at $58.4B. The stock traded near the top of its 52-week range of $139.29 to $216.74, carrying net debt of $15.6B.